Heptares Therapeutics

Nov 19, 2019

Sosei Heptares Creates New World-Class International Scientific Advisory Board to Support Strategic Decision-Making Aligned with Corporate Objectives

Oct 05, 2017

Heptares Founder Richard Henderson Receives Nobel Prize in Chemistry 2017 for Pioneering Work in Cryo-EM for Visualising Biological Structures

Aug 31, 2017

First Subject Dosed in Phase 1 Clinical Study of Novel Selective MUSCARINIC M4 Agonist in Development to Treat Major Symptoms of Alzheimer's Disease

Aug 31, 2017

Heptares Enters a New Research and Drug Discovery Collaboration Under its 'Orbit' Initiative with Juntendo University

Jul 13, 2017

Heptares Hosts Scientific Symposium in Celebration Of 10-year Anniversary

Jun 29, 2017

Heptares and PeptiDream Enter Strategic Collaboration to Discover, Develop and Commercialise Novel Therapeutics in Inflammatory Disease

Jun 28, 2017

Heptares Enters a New Research and Drug Discovery Collaboration Under its "Orbit" Initiative With New York University School of Medicine

Jun 20, 2017

Heptares Plans Relocation to Cambridge, UK

May 31, 2017

Heptares Solves First Full-length Structure of GLP-1 Receptor Bound to Peptide Agonist